BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1077 related articles for article (PubMed ID: 21044653)

  • 21. The association between brain-derived neurotrophic factor Val66Met variants and psychotic symptoms in posttraumatic stress disorder.
    Pivac N; Kozaric-Kovacic D; Grubisic-Ilic M; Nedic G; Rakos I; Nikolac M; Blazev M; Muck-Seler D
    World J Biol Psychiatry; 2012 Apr; 13(4):306-11. PubMed ID: 21728904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.
    Chen SL; Lee SY; Chang YH; Chen SH; Chu CH; Wang TY; Chen PS; Lee IH; Yang YK; Hong JS; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():99-104. PubMed ID: 24468644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain-derived neurotrophic factor Val66Met polymorphism and alcohol-related phenotypes.
    Nedic G; Perkovic MN; Sviglin KN; Muck-Seler D; Borovecki F; Pivac N
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():193-8. PubMed ID: 23023098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
    Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
    Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review.
    Notaras M; Hill R; van den Buuse M
    Neurosci Biobehav Rev; 2015 Apr; 51():15-30. PubMed ID: 25562189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood trauma, BDNF Val66Met and subclinical psychotic experiences. Attempt at replication in two independent samples.
    de Castro-Catala M; van Nierop M; Barrantes-Vidal N; Cristóbal-Narváez P; Sheinbaum T; Kwapil TR; Peña E; Jacobs N; Derom C; Thiery E; van Os J; van Winkel R; Rosa A
    J Psychiatr Res; 2016 Dec; 83():121-129. PubMed ID: 27596955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients.
    Zhou DH; Yan QZ; Yan XM; Li CB; Fang H; Zheng YL; Zhang CX; Yao HJ; Chen DC; Xiu MH; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):930-3. PubMed ID: 20420877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism.
    Sotiropoulou M; Mantas C; Bozidis P; Marselos M; Mavreas V; Hyphantis T; Antoniou K
    Life Sci; 2013 Mar; 92(4-5):305-10. PubMed ID: 23333821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aki H; Sumitani S; Itakura M; Ohmori T
    J Neural Transm (Vienna); 2007 Feb; 114(2):255-9. PubMed ID: 16897602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease.
    Fehér A; Juhász A; Rimanóczy A; Kálmán J; Janka Z
    Alzheimer Dis Assoc Disord; 2009; 23(3):224-8. PubMed ID: 19812463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies.
    Kheirollahi M; Kazemi E; Ashouri S
    Cell Mol Neurobiol; 2016 Jan; 36(1):1-10. PubMed ID: 26134309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of effect of brain derived neurotrophic factor (BDNF) Val66Met polymorphism on early onset schizophrenia in Chinese Han population.
    Yi Z; Zhang C; Wu Z; Hong W; Li Z; Fang Y; Yu S
    Brain Res; 2011 Oct; 1417():146-50. PubMed ID: 21917241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence.
    Zhang H; Ozbay F; Lappalainen J; Kranzler HR; van Dyck CH; Charney DS; Price LH; Southwick S; Yang BZ; Rasmussen A; Gelernter J
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jun; 141B(4):387-93. PubMed ID: 16649215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced severity of posttraumatic stress disorder associated with Val allele of Val66Met polymorphism at brain-derived neurotrophic factor gene among Chinese adolescents after Wenchuan earthquake.
    Li RH; Fan M; Hu MS; Ran MS; Fang DZ
    Psychophysiology; 2016 May; 53(5):705-11. PubMed ID: 26751724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants.
    Pivac N; Kim B; Nedić G; Joo YH; Kozarić-Kovacić D; Hong JP; Muck-Seler D
    Croat Med J; 2009 Feb; 50(1):43-8. PubMed ID: 19260143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study.
    Kirli U; Binbay T; Drukker M; Elbi H; Kayahan B; Gökçelli DK; Özkınay F; Onay H; Alptekin K; van Os J
    Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):113-121. PubMed ID: 29785763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
    Nikolac Perkovic M; Nedic Erjavec G; Zivkovic M; Sagud M; Uzun S; Mihaljevic-Peles A; Kozumplik O; Muck-Seler D; Pivac N
    Psychopharmacology (Berl); 2014 Sep; 231(18):3757-64. PubMed ID: 24595507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
    Huang E; Hettige NC; Zai G; Tomasi J; Huang J; Zai CC; Pivac N; Nikolac Perkovic M; Tiwari AK; Kennedy JL
    Pharmacogenomics J; 2019 Jun; 19(3):269-276. PubMed ID: 30181602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.